Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
18 April 2014
Header
Header image
Highlight of the week

News

Responsible Transparency: getting ready for disclosure. Campaign launched to raise awareness of new financial disclosure rules
14 April 2014

Less than 9 months left until Disclosure Code comes operationally into force (14 April 2014 – Brussels): As part of the European Federation of Pharmaceutical Industries [...] Read more

News

News

European Parliament ITRE committee adopts IMI2 regulation
15 April 2014

EFPIA welcomes the adoption of the IMI2 regulation by the European Parliament's ITRE committee, another step towards the launch of the second Innovative Medicines Initiative. IMI2 [...] Read more

From our blog

From our blog

Collaborative Research Gets a Boost with Project Data Sphere Launch
14 April 2014 by Richard Bergström

Competition is a vital part of any industry. But sometimes competition needs to be put aside in the interest of progress. This is something the [...] Read more

From our blog

Aiming for a #HealthyEU – Countdown to European Elections – 5 weeks to go
17 April 2014 by Richard Torbett

Supporting Sustainable Healthcare Systems: EFPIA’s Chief Economist, Dr. Richard Torbett, continues the #HealthyEU blog series with a discussion of collaborative approaches to health policy that are [...] Read more

Events calendar

Events Calendar

7th European Conference on Rare Diseases & Orphan Products
From 08/05/2014 to 10/05/2014 (Berlin, Germany )

The European Conference on Rare Diseases and Orphan Products is rare. It is the one event where everyone from patients, to policy makers, healthcare professionals, industry, payers, [...] Read more

What we are reading

What we are reading

Innovations for disease control
16 April 2014

To mark World Health Day, The Guardian asked their community to send in innovations they had seen that aim to tackle vector-borne diseases. Here are their favourites. 

Read more

What we are reading

Alzheimer’s Therapy May Come From New Look at Old Drugs
16 April 2014

An effort to find new uses for drugs that have failed in clinical trials may offer hope for Alzheimer’s patients, a top U.S. health research scientist said.

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail